CompletedNot Applicable

High Flow Nasal Cannula Therapy in Bronchiolitis : Early vs Rescue

Qatar28 participantsStarted 2018-08-14

Plain-language summary

The enrolled RSV-bronchiolitis patients will be randomized into two arms , the early HHHFNC group and the standard therapy group with rescue HHHFNC to study the efficacy of this treatment.

Who can participate

Age range3 Months

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Exclusion criteria

✕. Gestational age less than 30 weeks.
✕. Previous history of wheezing.
✕. Use of steroid within 48 hours of presentation.
✕. History of chronic lung disease.
✕. Infants admitted directly to ICU.
✕. Prior invasive or non-invasive ventilatory support.
✕. Tracheostomy.
✕. Nasogastric tubes in situ on admission.

What they're measuring

The rate of Pediatric Intensive Care Unit (PICU) admissions

Timeframe: Through study completion, an average of 3 year

Trial details

NCT IDNCT03095495

SponsorHamad Medical Corporation

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2024-05-28

View on ClinicalTrials.gov More Bronchiolitis trials